Analytical Data
-
Gene name
BLMH
- Application
-
Alternative Names
BLMH；Bleomycin hydrolase
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13867
-
Expression Region
1-475aa
-
AA Sequence
MGSSHHHHHHSSGLVPRGSHMSSSGLNSEKVAALIQKLNSDPQFVLAQNV GTTHDLLDICLKRATVQRAQHVFQHAVPQEGKPITNQKSS GRCWIFSCLNVMRLPFMKKLNIEEFEFSQSYLFFWDKVERCYFFLSAFVD TAQRKEPEDGRLVQFLLMNPANDGGQWDMLVNIVEKYGVIPKKCFPESYT TEATRRMNDILNHKMREFCIRLRNLVHSGATKGEISATQD VMMEEIFRVV CICLGNPPET FTWEYRDKDK NYQKIGPITP LEFYREHVKP LFNMEDKICL VNDPRPQHKY NKLYTVEYLS NMVGGRKTLY NNQPIDFLKK MVAASIKDGE AVWFGCDVGK HFNSKLGLSD MNLYDHELVF GVSLKNMNKA ERLTFGESLM THAMTFTAVS EKDDQDGAFT KWRVENSWGE DHGHKGYLCM TDEWFSEYVY EVVVDRKHVP EEVLAVLEQE PIILPAWDPM GALAE
-
Molecular Weight
55 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BLMH (Benzenesulfonamide-Like Molecule Homolog) is a protein of significant interest in biomedical research due to its potential role in various physiological processes and diseases. The study of BLMH has gained traction because of its involvement in cellular signaling pathways, particularly in relation to inflammatory responses and cardiovascular health. Recent investigations have highlighted BLMH's function as an enzyme stimulating the hydrolysis of certain compounds, making it critical in metabolism and drug metabolism. Additionally, its structural characteristics have attracted attention for protein engineering efforts aimed at enhancing its therapeutic effectiveness. Understanding the underlying mechanisms of BLMH can provide insights into developing targeted therapies for conditions like heart disease and obesity. Research into BLMH is further motivated by the need for novel biomolecules that can serve as biomarkers or therapeutic agents, enhancing both diagnosis and treatment strategies in clinical settings. As such, the recombination and characterization of BLMH offer valuable opportunities for advancing our knowledge of metabolic disorders and improving therapeutic interventions.
